Publications:

Application of proprotein convertase subtilisin/kexin type 9 inhibitor, evolocumab, in patients with severe hypertriglyceridemia.

Chinese Medical Journal

Peng, Yanren Y; Guo, Danxia D; Jiang, Sijie S; Zheng, Hua H

Publication Date: 2022-03-20

Variant appearance in text: rs3735959

PubMed Link: 34924503

Variant Present in the following documents:

• Main text
• cm9-135-730.pdf

View BVdb publication page

Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias.

Bmc Medical Genomics

Dron, Jacqueline S JS; Wang, Jian J; McIntyre, Adam D AD; Iacocca, Michael A MA; Robinson, John F JF; Ban, Matthew R MR; Cao, Henian H; Hegele, Robert A RA

Publication Date: 2020-02-10

Variant appearance in text: LPL: 429+20A>C

PubMed Link: 32041611

Variant Present in the following documents:

• 12920_2020_669_MOESM1_ESM.xlsx, sheet 3

View BVdb publication page